Importantly, overexpression of COX-2 is associated with poor survival of CRC patients [190], whereas selective COX-2 inhibition in colon cancer cells has shown to suppress tumor growth and to induce apoptosis as well as cell-cycle arrest [191, 192]. Here, PTGS2 is linked to malignant colon neoplasm.